[{"id": 609657, "created": "2025-07-26T14:13:33.988373", "project_id": 291, "task_id": 647105, "user_id": 315, "user_ip": null, "finish_time": "2025-07-26T14:19:15.282959", "timeout": null, "calibration": null, "external_uid": null, "media_url": null, "info": {"id": "n215590866", "text": " By Anuron Kumar Mitra  BENGALURU - Indian shares rose on Friday, boosted by pharma stocks after Dr.Reddy's hit a record high, and as broader Asian markets gained on hopes of more monetary support from central banks. The blue-chip NSE Nifty 50 index rose 0.34% to 11,555.90 and the benchmark S&P BSE Sensex 0.17% to 39,046.18 by 0455 GMT. Both the indexes closed more than 0.7% lower on Thursday. The Nifty Pharma index was the biggest boost to the markets, rising 4.4% following Dr.Reddy's near-7% jump. The pharmaceutical firm also hit an all-time high and was the top boost to the Nifty 50 as it settled a patent litigation with Bristol-Myers Squibb Co over the cancer treatment Revlimid. \"Other generic players like Cadila Healthcare, Sun Pharma... are currently into litigation on Revlimid and there is a chance that we can see... a settlement with these players as well,\" analysts at Nirmal Bang Institutional Equities said in a note. Cadila Healthcare Ltd and Sun Pharmaceutical Industries Ltd gained as much as 3.4% and 3.5%, respectively. Separately, drugmaker Perrigo Company Plc on Thursday issued a U.S. nationwide recall of its albuterol sulfate inhalation aerosol product due to complaints over clogging issues. \"We see the (Perrigo recall) as a material positive development for both Cipla and Lupin,\" said analysts at Ambit Capital Pvt Ltd in a note. Both the companies have their own versions of the aerosol product approved by the U.S. FDA. Cipla Ltd shares rose as much as 6.5%, Lupin Ltd jumped as much as 7.2% to hit a more than three-year high. Consumer goods giant Hindustan Unilever Ltd was the top drag on the Nifty, shedding as much as 1.8%. Meanwhile, broader Asian markets rose after central bankers globally indicated their readiness to provide further stimulus to help economic recovery. (Reporting by Anuron Kumar Mitra in Bengaluru; editing by Uttaresh.V) ", "clarity": "clear", "headline": "Pharma stocks lift Indian markets; Dr.Reddy`s hits record high", "faithfulness": "faithful", "plausibility": "plausible", "informativeness": "informative"}}, {"id": 615859, "created": "2025-08-05T08:03:16.900874", "project_id": 291, "task_id": 647105, "user_id": 325, "user_ip": null, "finish_time": "2025-08-05T08:04:20.071749", "timeout": null, "calibration": null, "external_uid": null, "media_url": null, "info": {"id": "n215590866", "text": " By Anuron Kumar Mitra  BENGALURU - Indian shares rose on Friday, boosted by pharma stocks after Dr.Reddy's hit a record high, and as broader Asian markets gained on hopes of more monetary support from central banks. The blue-chip NSE Nifty 50 index rose 0.34% to 11,555.90 and the benchmark S&P BSE Sensex 0.17% to 39,046.18 by 0455 GMT. Both the indexes closed more than 0.7% lower on Thursday. The Nifty Pharma index was the biggest boost to the markets, rising 4.4% following Dr.Reddy's near-7% jump. The pharmaceutical firm also hit an all-time high and was the top boost to the Nifty 50 as it settled a patent litigation with Bristol-Myers Squibb Co over the cancer treatment Revlimid. \"Other generic players like Cadila Healthcare, Sun Pharma... are currently into litigation on Revlimid and there is a chance that we can see... a settlement with these players as well,\" analysts at Nirmal Bang Institutional Equities said in a note. Cadila Healthcare Ltd and Sun Pharmaceutical Industries Ltd gained as much as 3.4% and 3.5%, respectively. Separately, drugmaker Perrigo Company Plc on Thursday issued a U.S. nationwide recall of its albuterol sulfate inhalation aerosol product due to complaints over clogging issues. \"We see the (Perrigo recall) as a material positive development for both Cipla and Lupin,\" said analysts at Ambit Capital Pvt Ltd in a note. Both the companies have their own versions of the aerosol product approved by the U.S. FDA. Cipla Ltd shares rose as much as 6.5%, Lupin Ltd jumped as much as 7.2% to hit a more than three-year high. Consumer goods giant Hindustan Unilever Ltd was the top drag on the Nifty, shedding as much as 1.8%. Meanwhile, broader Asian markets rose after central bankers globally indicated their readiness to provide further stimulus to help economic recovery. (Reporting by Anuron Kumar Mitra in Bengaluru; editing by Uttaresh.V) ", "clarity": "very_clear", "headline": "Pharma stocks lift Indian markets; Dr.Reddy`s hits record high", "faithfulness": "very_faithful", "plausibility": "highly_plausible", "informativeness": "informative"}}]